The global demand for Precision Medicine Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
The precision medicine, also known as personalized medicines, is the upcoming trend in the healthcare sector that grows rapidly over the years. Precision medicine is based on a unique concept that defines, two people infected with the same disease don't need to have the same physical response toward the disorder. However, it depends on the surrounding environment and the influence of genes and symptoms of the patient. Moreover, it also depends on patients' ability to respond to that particular disease, enabling the doctors and researchers to organize the necessary treatment. Precision medicine mainly includes system biology and panomics to examine the reason for an individual patient's illness at the molecular level. Followed by the use of concentrated medications to address individual patient's ailments. Precision medicine offers many benefits, such as efficient treatment customized to patients' needs and disease categories. Moreover, precision medicine can reduce the cost of treatment and help decrease repeated administration of medications.
Market Dynamics
The market is mainly driven by increasing approval of the drug and its companion diagnostic assay, cost-effective profiling of DNA, increasing incidence of cancer, and the rise of data-driven healthcare. In addition, the rising use of “multi-omics” in research, along with the penetration of high-throughput sequencing platforms, is also surging up the precision medicine scenario. The number of targeted molecules in the pipeline for a specific application has been exponentially growing, specifically in oncology has created a new opportunity over the forecast period. The current escalating price of drug discovery and increasing regulatory requirements have increased the demand for an individualized product. The development of companion diagnostics appears to offer a set of tools and relevant clinical and biological information to address various pharmaceutical companies.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of precision medicine. The growth and trends of precision medicine industry provide a holistic approach to this study.
Market Segmentation
This section of the precision medicine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Technology
- Genomics
- Transcriptomics
- Epigenomics
By Sequencing Technology
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Pyrosequencing
- Single Molecule Real Time Sequencing
- Chain Termination Sequencing
- Nanopore Sequencing
By Product
- Consumables
- Instruments
- Services
By Application
- Oncology
- CNS
- Immunology
- Respiratory Medicine
- Infections
- Others Applications
By End User
- Diagnostic Tool companies
- Pharma & Biotech Companies
- Clinical Laboratories
- Healthcare IT/ Big Data Companies
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Precision Medicine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Precision Medicine Market Share by Region (Representative Graph)

Know more about this report: Download free sample
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the precision medicine market include Roche Holding AG, Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN, Quest Diagnostics, Laboratory Corporation of America Holdings, Novartis AG, AstraZeneca, Bristol-Myers Squibb, Eli Lilly & Company and others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1. PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2. EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3. PRECISION MEDICINE – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 By Technology
3.7.2 By Sequencing Technology
3.7.3 By Product
3.7.4 By Application
3.7.5 By End User
3.7.6 By Region
4. VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5. IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY TECHNOLOGY
6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 Genomics Market by Regions
6.5 Transcriptomics Market by Regions
6.6 Epigenomics Market by Regions
7. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY SEQUENCING TECHNOLOGY
7.1 Overview by Sequencing Technology
7.2 Historical and Forecast Data
7.3 Analysis by Sequencing Technology
7.4 Sequencing by Synthesis Market by Regions
7.5 Ion Semiconductor Sequencing Market by Regions
7.6 Sequencing by Ligation Market by Regions
7.7 Pyrosequencing Market by Regions
7.8 Single Molecule Real Time Sequencing Market by Regions
7.9 Chain Termination Sequencing Market by Regions
7.10. Nanopore Sequencing Market by Regions
8. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY PRODUCT
8.1 Overview by Product
8.2 Historical and Forecast Data
8.3 Analysis by Product
8.4 Consumables Market by Regions
8.5 Instruments Market by Regions
8.6 Services Market by Regions
9. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY APPLICATION
9.1 Overview by Application
9.2 Historical and Forecast Data
9.3 Analysis by Application
9.4 Oncology Market by Regions
9.5 CNS Market by Regions
9.6 Immunology Market by Regions
9.7 Respiratory Medicine Market by Regions
9.8 Infections Market by Regions
9.9 Others Applications Market by Regions
10. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY END USER
10.1 Overview by End User
10.2 Historical and Forecast Data
10.3 Analysis by End User
10.4 Diagnostic Tool companies Market by Regions
10.5 Pharma & Biotech Companies Market by Regions
10.6 Clinical Laboratories Market by Regions
10.7 Healthcare IT/ Big Data Companies Market by Regions
11. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY GEOGRAPHY
11.1. Regional Outlook
11.2. Introduction
11.3. North America
11.3.1. Overview, Historic and Forecast Data
11.3.2. North America By Segment
11.3.3. North America By Country
11.3.4. United State
11.3.5. Canada
11.3.6. Mexico
11.4. Europe
11.4.1. Overview, Historic and Forecast Data
11.4.2. Europe by Segment
11.4.3. Europe by Country
11.4.4. United Kingdom
11.4.5. France
11.4.6. Germany
11.4.7. Italy
11.4.8. Russia
11.4.9. Rest Of Europe
11.5. Asia Pacific
11.5.1. Overview, Historic and Forecast Data
11.5.2. Asia Pacific by Segment
11.5.3. Asia Pacific by Country
11.5.4. China
11.5.5. India
11.5.6. Japan
11.5.7. South Korea
11.5.8. Australia
11.5.9. Rest Of Asia Pacific
11.6. Latin America
11.6.1. Overview, Historic and Forecast Data
11.6.2. Latin America by Segment
11.6.3. Latin America by Country
11.6.4. Brazil
11.6.5. Argentina
11.6.6. Peru
11.6.7. Chile
11.6.8. Rest of Latin America
11.7. Middle East & Africa
11.7.1. Overview, Historic and Forecast Data
11.7.2. Middle East & Africa by Segment
11.7.3. Middle East & Africa by Country
11.7.4. Saudi Arabia
11.7.5. UAE
11.7.6. Israel
11.7.7. South Africa
11.7.8. Rest Of Middle East And Africa
12. COMPETITIVE LANDSCAPE OF THE PRECISION MEDICINE COMPANIES
12.1. Precision Medicine Market Competition
12.2. Partnership/Collaboration/Agreement
12.3. Merger And Acquisitions
12.4. New Product Launch
12.5. Other Developments
13. COMPANY PROFILES OF PRECISION MEDICINE INDUSTRY
13.1. Company Share Analysis
13.2. Market Concentration Rate
13.3. Roche Holding AG
13.3.1. Company Overview
13.3.2. Financials
13.3.3. Products
13.3.4. Recent Developments
13.4. Illumina Inc.
13.4.1. Company Overview
13.4.2. Financials
13.4.3. Products
13.4.4. Recent Developments
13.5. Thermo Fisher Scientific Inc.
13.5.1. Company Overview
13.5.2. Financials
13.5.3. Products
13.5.4. Recent Developments
13.6. QIAGEN
13.6.1. Company Overview
13.6.2. Financials
13.6.3. Products
13.6.4. Recent Developments
13.7. Quest Diagnostics
13.7.1. Company Overview
13.7.2. Financials
13.7.3. Products
13.7.4. Recent Developments
13.8. Laboratory Corporation of America Holdings
13.8.1. Company Overview
13.8.2. Financials
13.8.3. Products
13.8.4. Recent Developments
13.9. Novartis AG
13.9.1. Company Overview
13.9.2. Financials
13.9.3. Products
13.9.4. Recent Developments
13.10. AstraZeneca
13.10.1. Company Overview
13.10.2. Financials
13.10.3. Products
13.10.4. Recent Developments
13.11. Bristol-Myers Squibb
13.11.1. Company Overview
13.11.2. Financials
13.11.3. Products
13.11.4. Recent Developments
13.12. Eli Lilly & Company
13.12.1. Company Overview
13.12.2. Financials
13.12.3. Products
13.12.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Technology (USD MN)
- Genomics Market by Geography (USD MN)
- Transcriptomics Market by Geography (USD MN)
- Epigenomics Market by Geography (USD MN)
- Analysis Market by Sequencing Technology (USD MN)
- Sequencing by Synthesis Market by Geography (USD MN)
- Ion Semiconductor Sequencing Market by Geography (USD MN)
- Sequencing by Ligation Market by Geography (USD MN)
- Pyrosequencing Market by Geography (USD MN)
- Single Molecule Real Time Sequencing Market by Geography (USD MN)
- Chain Termination Sequencing Market by Geography (USD MN)
- Nanopore Sequencing Market by Geography (USD MN)
- Analysis by Product (USD MN)
- Consumables Market by Geography (USD MN)
- Instruments Market by Geography (USD MN)
- Services Market by Geography (USD MN)
- Analysis by Application (USD MN)
- Oncology Market by Geography (USD MN)
- CNS Market by Geography (USD MN)
- Immunology Market by Geography (USD MN)
- Respiratory Medicine Market by Geography (USD MN)
- Infections Market by Geography (USD MN)
- Others Applications Market by Geography (USD MN)
- Analysis by End User (USD MN)
- Diagnostic Tool companies Market by Geography (USD MN)
- Pharma & Biotech Companies Market by Geography (USD MN)
- Clinical Laboratories Market by Geography (USD MN)
- Healthcare IT/ Big Data Companies Market by Geography (USD MN)
- Global Precision Medicine Market by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisiton
LIST OF FIGURES
- Research Scope of Precision Medicine Report
- Market Research Process
- Market Research Methodology
- Global Precision Medicine Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Technology
- Market Attractiveness Analysis by Sequencing Technology
- Market Attractiveness Analysis by Product
- Market Attractiveness Analysis by Application
- Market Attractiveness Analysis by End User
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Technology (USD MN)
- Genomics Market by Geography (USD MN)
- Transcriptomics Market by Geography (USD MN)
- Epigenomics Market by Geography (USD MN)
- Global Market Analysis by Sequencing Technology (USD MN)
- Sequencing by Synthesis Market by Geography (USD MN)
- Ion Semiconductor Sequencing Market by Geography (USD MN)
- Sequencing by Ligation Market by Geography (USD MN)
- Pyrosequencing Market by Geography (USD MN)
- Single Molecule Real Time Sequencing Market by Geography (USD MN)
- Chain Termination Sequencing Market by Geography (USD MN)
- Nanopore Sequencing Market by Geography (USD MN)
- Global Market Analysis by Product (USD MN)
- Consumables Market by Geography (USD MN)
- Instruments Market by Geography (USD MN)
- Services Market by Geography (USD MN)
- Global Market Analysis by Application (USD MN)
- Oncology Market by Geography (USD MN)
- CNS Market by Geography (USD MN)
- Immunology Market by Geography (USD MN)
- Respiratory Medicine Market by Geography (USD MN)
- Infections Market by Geography (USD MN)
- Others Applications Market by Geography (USD MN)
- Global Market Analysis by End User (USD MN)
- Diagnostic Tool companies Market by Geography (USD MN)
- Pharma & Biotech Companies Market by Geography (USD MN)
- Clinical Laboratories Market by Geography (USD MN)
- Healthcare IT/ Big Data Companies Market by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Company Market Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.